Advances in Myelofibrosis Treatments: Insights with Dr. Marina Kremyanskaya

Published on December 4, 2024

We recently had the pleasure of hosting an informal talk with Dr. Marina Kremyanskaya (Mount Sinai, New York), an expert in Myeloproliferative Neoplasms (MPNs), to discuss the latest insights and challenges in MPN treatment. In this session, Dr. Kremyanskaya shared her extensive knowledge on the current treatment landscape and answered questions from patients and caregivers, offering a unique perspective on the future of MPN care.

 

 

 

 

 

 

 

 

 

 

Part 1: Discussing PV and ET with Dr. Kremyanskaya

In a recent conversation with Dr. Marina Kremyanskaya from Mount Sinai Hospital, we dove into the latest advancements in treating Polycythemia Vera (PV) and Essential Thrombocythemia (ET). The discussion highlighted the importance of patient-specific approaches, particularly when deciding between treatments like interferon or hydroxyurea. 

https://vimeo.com/986522238/be261fe300 



Part 2: Myelofibrosis Management and Risk Stratification

Dr. Kremyanskaya highlighted key factors for risk stratification in Myelofibrosis (MF), such as age, genetic mutations, and blood counts. Latest treatments like JAK inhibitors (e.g., Ruxolitinib and Momelotinib) have made significant progress in managing symptoms like splenomegaly and anemia.

https://vimeo.com/990056130/430b771c3a 

 

Other news

Join Us at the 66th ASH Annual Meeting

December 4, 2024
We are excited to announce our participation in the 66th ASH Annual Meeting and Exposition, a key event for hematology professionals worldwide. Taking place from December 7-10, 2024, in San Diego, California, ASH 2024 will feature the latest advancements in both classical and malignant hematology.           During the event, Peter Loffelhardt, Founder and President of the Global MPN Scientific Fou

Webinar: What is a Combo Treatment in MPN?

December 12, 2024
Our last webinar of the year is a special opportunity to learn about combo treatments in the context of MPNs. On Monday, December 23rd, 2024, from 5 PM to 7 PM (CET), Global MPN Scientific Foundation is hosting a roundtable discussion to explore a new potential treatment and the role of combination therapies in MPN management. We are thrilled to be joined by Karyopharm, a pharmaceutical company wi